MongoDB, Inc. (MDB) Stock Price & Analysis
MongoDB, Inc. (MDB) closed at USD 362.24 on Thursday, October 22, 2026, down 7.30% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 390.75; the Oct 22, 2026 session ranged USD 359.9–386.58 on volume of 2,048,296 shares. Market capitalization is $29.14B, with a 52-week range of USD 215.68–473.1 (NGM). Source: Nexqual, retrieved October 23, 2026 at 08:44 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MDB.md
Key facts (MDB)
- Last four reported quarters (through Jul 31, 2026): revenue $2.78B, net income $58.9M (2.1% margin), free cash flow $659M (SEC filings).
- Valuation: P/E 494.7x.
- 1 of 80 tracked superinvestors hold MDB (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 18 Form 4 filings, $70.6M; 2 not under a Rule 10b5-1 plan ($32.9M); 0 by opportunistic insiders, 13 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (40 analysts), mean target USD 452.5 (range 335–565).
- Total return with dividends: 1Y +9.8% vs S&P 500 +14.9%; 5Y -28.3% vs S&P 500 +80.3%.
- Next earnings: 2026-12-01, EPS estimate USD 1.61, revenue estimate $762M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MDB)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $874M | $1.28B | $1.68B | $2.01B | $2.46B | $2.78B |
| Gross profit | $614M | $935M | $1.26B | $1.47B | $1.77B | — |
| Operating income | -$289M | -$347M | -$234M | -$216M | -$137M | -$14.5M |
| Net income | -$307M | -$345M | -$177M | -$129M | -$71.2M | $58.9M |
| EPS (diluted) | -$4.75 | -$5.03 | -$2.48 | -$1.73 | -$0.88 | — |
| Free cash flow | -$1.1M | -$20.2M | $115M | $121M | $500M | $659M |
| Gross margin | 70.3% | 72.8% | 74.8% | 73.3% | 71.7% | — |
| Operating margin | -33.1% | -27.0% | -13.9% | -10.8% | -5.6% | -0.5% |
| Net margin | -35.1% | -26.9% | -10.5% | -6.4% | -2.9% | 2.1% |
| Revenue growth | +48.0% | +47.0% | +31.1% | +19.2% | +22.8% | — |
| Cash + short-term investments | $1.83B | $1.84B | $2.02B | $2.34B | $2.39B | — |
| Total debt | $1.14B | $1.14B | $1.14B | $0K | — | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 31, 2026) (MDB)
P/E 494.7x · P/S 10.5x · P/FCF 44.2x · P/B 9.8x · FCF yield 2.26% · Earnings yield 0.20% · Buyback yield (TTM) 1.39%
Superinvestors (SEC 13F-HR, Q2 2026) (MDB)
1 of 80 tracked investors hold MDB. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| ValueAct Capital | 0.99% | $55.7M | Reduced -84.0% |
Insider sales (SEC Form 4, open-market, last ~7 months) (MDB)
16 of 18 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Agrawal Archana | Director | 1,000 | $400K | 18.8% | Yes | Too little history (no open-market trades in 2023 or 2025) |
| 2026-10-08…2026-10-09 | Merriman Dwight A | Director | 14,000 | $5.1M | 0.9% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025) |
| 2026-10-06 | Hazard Charles M Jr | Director | 595 | $216K | 0.8% | Yes | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-17 | Cochran Hope F | Director | 1,000 | $376K | 3.4% | Yes | Routine (sold in Apr & Jun & Sep & Dec each year 2023–2025) |
| 2026-08-14…2026-08-17 | Merriman Dwight A | Director | 16,000 | $7.4M | 1.1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025; this trade is outside those months) |
| 2026-07-14…2026-07-16 | Merriman Dwight A | Director | 16,000 | $5.2M | 1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025) |
| 2026-07-01 | Cochran Hope F | Director | 1,000 | $350K | 3.3% | Yes | Routine (sold in Apr & Jun & Sep & Dec each year 2023–2025; this trade is outside those months) |
| 2026-06-30 | Merriman Dwight A | Director | 1,130 | $378K | 0.1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025) |
| 2026-06-17 | Cochran Hope F | Director | 1,566 | $539K | 5.1% | Yes | Routine (sold in Apr & Jun & Sep & Dec each year 2023–2025) |
| 2026-06-16 | Berry Michael J | Chief Financial Officer | 5,000 | $1.8M | 5.5% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-15 | Berry Michael J | Chief Financial Officer | 5,000 | $1.8M | 5.2% | Yes | Too little history (no open-market trades in 2023–2025) |
| 2026-06-12…2026-06-15 | Merriman Dwight A | Director | 16,000 | $5.6M | 1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025) |
| 2026-06-04 | Ittycheria Dev | Director | 40,000 | $15.3M | 19.8% | No | Routine (sold in Jan & Feb & Apr & Jul each year 2023–2025; this trade is outside those months) |
| 2026-06-02 | Botha Roelof | Director | 44,050 | $17.5M | 22.5% | No | Too little history (no open-market trades in 2023) |
| 2026-05-29 | Cochran Hope F | Director | 1,000 | $350K | 3.6% | Yes | Routine (sold in Apr & Jun & Sep & Dec each year 2023–2025; this trade is outside those months) |
| 2026-05-14…2026-05-18 | Merriman Dwight A | Director | 16,000 | $4.9M | 1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025; this trade is outside those months) |
| 2026-05-07 | Merriman Dwight A | Director | 2,000 | $580K | 0.1% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025; this trade is outside those months) |
| 2026-04-14…2026-04-16 | Merriman Dwight A | Director | 12,000 | $2.9M | 0.8% | Yes | Routine (sold in Jan & Feb & Mar & Jun & Jul & Sep & Oct & Nov & Dec each year 2023–2025; this trade is outside those months) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (MDB)
Consensus Buy (mean 2.00 on a 1–5 scale), 40 analysts; mean target USD 452.5 (low 335, high 565).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | Needham | Reiterated | Buy | $430 |
| 2026-10-08 | Scotiabank | Target raised | Sector Outperform | $440 → $450 |
| 2026-10-02 | Cantor Fitzgerald | Reiterated | Overweight | $540 |
| 2026-10-01 | DA Davidson | Maintained | Buy | $415 |
| 2026-09-30 | DA Davidson | Target lowered | Buy | $465 → $415 |
| 2026-09-30 | UBS | Target lowered | Neutral | $410 → $375 |
| 2026-09-30 | Macquarie | Maintained | Neutral | $375 |
| 2026-09-30 | Citizens | Reiterated | Market Outperform | $519 |
| 2026-09-30 | RBC Capital | Reiterated | Outperform | $465 |
| 2026-09-30 | BMO Capital | Target lowered | Outperform | $450 → $420 |
| 2026-09-30 | Guggenheim | Reiterated | Buy | $560 |
| 2026-09-30 | Stifel | Target lowered | Buy | $465 → $385 |
Total return (dividends reinvested) (MDB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +9.8% | -28.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +9.8% | -6.4% |
| Volatility (annualized) | 72.5% | 68.8% |
| Max drawdown | -48.7% (Jan 2026→Apr 2026) | -74.5% (Nov 2021→Oct 2022) |
MDB revenue by product line (quarter ended Jul 31, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Subscription | $747.1M | 96.8% | +30.5% |
| — Atlas-related (part of Subscription) | $565.9M | 73.3% | +28.9% |
| — MongoDB Enterprise Advanced and other (part of Subscription) | $181.2M | 23.5% | +35.9% |
| Services | $24.6M | 3.2% | +29.3% |
| Total revenue | $771.8M | 100% | — |
MDB revenue by region (quarter ended Jul 31, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Americas | $478.3M | 62.0% | +31.3% |
| EMEA | $210.3M | 27.2% | +30.7% |
| Asia Pacific | $83.2M | 10.8% | +25.7% |
| Total revenue | $771.8M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
MDB suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Alphabet (Google) (GOOGL) | “Built for resilience, scale, and security, Atlas is available in more than 130 regions worldwide across all three major cloud providers (Amazon Web Services ("AWS"), Google Cloud Platform ("GCP") and Microsoft Azure), enabling our customers to leverage the benefits of different cloud platforms for different use cases with broader geographic reach and helping them avoid infrastructure vendor lock-in.” |
| Partner | Tencent | “We have expanded our global partner ecosystem with Alibaba Cloud and Tencent Cloud to offer an authorized MongoDB-as-a-Service solution in China, allowing their customers to easily adopt and consume our hosted solution.” |
| Partner | Alibaba (BABA) | “We have expanded our global partner ecosystem with Alibaba Cloud and Tencent Cloud to offer an authorized MongoDB-as-a-Service solution in China, allowing their customers to easily adopt and consume our hosted solution.” |
| Partner | Accenture (ACN) | “We have also expanded our existing partnerships with independent software vendors and global systems integrators including IBM, Accenture, Infosys, Capgemini, Confluent, HCL, Wipro, Cognizant, Deloitte and Tata Consultancy Services.” |
| Competitor | Microsoft (MSFT) | “We primarily compete with established legacy database software providers such as IBM, Microsoft, Oracle and other similar companies.” |
| Competitor | Amazon (AMZN) | “We also compete with public cloud providers that offer database functionality, such as AWS, GCP and Microsoft Azure as well as other database software providers.” |
| Competitor | IBM (IBM) | “We primarily compete with established legacy database software providers such as IBM, Microsoft, Oracle and other similar companies.” |
| Competitor | Oracle (ORCL) | “We primarily compete with established legacy database software providers such as IBM, Microsoft, Oracle and other similar companies.” |
Quoted from the company's 10-K filed Mar 11, 2026.
MDB company outlook (results filed Sep 1, 2026)
- “Based on information available to management as of today, September 1, 2026, MongoDB is issuing the following financial guidance for the third quarter fiscal 2027.”
Quoted word-for-word from the SEC 8-K results press release.
MDB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $1.61 | $1.51 | +6.6% | $761.8M | 36 |
| Next quarter (ends Jan 2027) | $1.71 | $1.66 | +3.1% | $806.3M | 35 |
| Current fiscal year (ends Jan 2027) | $6.54 | $6.13 | +6.8% | $3.02B | 38 |
| Next fiscal year (ends Jan 2028) | $7.87 | $7.34 | +7.3% | $3.61B | 39 |
MDB options: expected move
Options price a move of about ±20.9% (±$75.08) by Dec 4, 2026, which includes earnings on Dec 1, 2026; the earnings reaction alone is priced at about ±11.5%. Over the last 8 reports the stock moved ±19% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 65.5% | ±7.8% |
| Nov 6, 2026 | 14 | 70.1% | ±11.4% |
| Nov 13, 2026 | 21 | 67.2% | ±13.2% |
| Nov 20, 2026 | 28 | 65.5% | ±14.8% |
| Nov 27, 2026 | 35 | 64.4% | ±16.2% |
| Dec 4, 2026 | 42 | 76.2% | ±20.9% |
| Dec 18, 2026 | 56 | 74.0% | ±23.3% |
| Jan 15, 2027 | 84 | 69.2% | ±26.6% |
30-day implied volatility 65.1% vs 84.7% realized over the last 30 trading days. Put/call ratio (volume) 0.99. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 08:44 UTC)
| Price | USD 362.24 |
|---|---|
| Change | ▼ 7.30% (down) |
| Previous Close | USD 390.75 |
| Open | USD 383.84 |
| Day Range | USD 359.9 – 386.58 |
| 52-Week Range | USD 215.68 – 473.1 |
| Volume | 2,048,296 shares |
| Market Cap | $29.14B |
| Exchange | NGM |
Technical Analysis (MDB)
Nexqual's technical model rates MDB "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 08:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 49.22 (neutral) |
| vs SMA50 | Below (USD 390.53) |
| MACD | -4.9 (negative) |
Analyst Ratings (MDB)
Wall Street analysts rate MDB "Buy" based on 40 analysts, with a mean price target of USD 452.5 (range USD 335–565), per Nexqual as of October 23, 2026 at 08:44 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 40 |
| Mean Target | USD 452.5 |
| High Target | USD 565 |
| Low Target | USD 335 |
| Buy / Hold / Sell | 32 / 8 / 0 |
Earnings (MDB)
| Next Earnings Date | 2026-12-01 |
|---|---|
| EPS Estimate | USD 1.61 |
| Revenue Estimate | $761.81M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 1.9 vs est 1.61 ▲ beat |
| 2026-04-30 | USD 1.32 vs est 1.18 ▲ beat |
| 2026-01-31 | USD 1.65 vs est 1.47 ▲ beat |
| 2025-10-31 | USD 1.32 vs est 0.79 ▲ beat |
Source: Nexqual, October 23, 2026 at 08:44 UTC.
Financials & Fundamentals (MDB)
| Total Revenue | $2.78B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +30.50% |
| Gross Margin | +72.69% |
| Operating Margin | +3.68% |
| Profit Margin | +2.12% |
| ROE | +1.99% |
| Debt / Equity | 0.02 |
| Current Ratio | 4.87 |
| Total Cash | $2.41B |
| Total Debt | $55.01M |
| Free Cash Flow (last four quarters to Jul 2026, SEC 10-Q / 10-K) | $659.02M (23.7% of revenue) |
Source: Nexqual, October 23, 2026 at 08:44 UTC.
Financial Health Score (MDB)
Nexqual rates MongoDB, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 08:44 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 4% (last 12 months) |
| Balance Sheet | Strong — $2.41B cash vs $55M debt, net cash position |
| Cash Flow | Strong — FCF $659M (last 4 quarters to Jul 2026, SEC), 24% margin |
| Efficiency | Weak — ROE 2%, ROA -0.2% |
Ownership (MDB)
| Insider Ownership | +2.62% |
|---|---|
| Institutional Ownership | +96.57% |
| Shares Outstanding | 80.43M |
| Float | 78.58M |
| Short % of Float | +3.61% |
Source: Nexqual, October 23, 2026 at 08:44 UTC.
Leadership (MDB)
MongoDB, Inc. is led by Dev C. Ittycheria, Interim President & CEO and Director, per Nexqual as of October 23, 2026 at 08:44 UTC.
| Interim President & CEO and Director | Dev C. Ittycheria |
|---|---|
| Co-Founder & Director | Dwight A. Merriman |
| CFO & Principal Financial Officer | Michael J. Berry |
| Chief Technology Officer | Jim Scharf |
| Vice President of Investor Relations | Jess Ian Lubert |
Major Backers & Investors (MDB)
Notable institutional backers of MongoDB, Inc. include FMR, LLC, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, Price (T.Rowe) Associates Inc, according to Nexqual as of October 23, 2026 at 08:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 4.54% |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 3.12% |
| Price (T.Rowe) Associates Inc | 2.58% |
| AQR Capital Management, LLC | 1.87% |
| NORGES BANK | 1.74% |
| Fidelity | 1.5% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 9.91% |
| BlackRock | 7.87% |
| State Street | 2.4% |
| Geode Capital | 1.93% |
Source: Nexqual, October 23, 2026 at 08:44 UTC.
From MongoDB, Inc.'s Latest SEC 10-K Filing (filed 2026-03-11)
Key Strengths & Strategy (as disclosed to the SEC)
- We have also expanded our existing partnerships with independent software vendors and global systems integrators including IBM, Accenture, Infosys, Capgemini, Confluent, HCL, Wipro, Cognizant, Deloitte and Tata Consultancy Services.
- According to the International Data Corporation (IDC)'s Worldwide Database Management Systems Software Forecast, 2025-2029, the worldwide Database Management Software market was $93 billion in 2024, growing to approximately $169 billion in 2029.
- The key differentiating features and capabilities of our developer data platform include: We Built Our Platform for Developers.
- Built for resilience, scale, and security, Atlas is available in more than 130 regions worldwide across all three major cloud providers (Amazon Web Services ("AWS"), Google Cloud Platform ("GCP") and Microsoft Azure), enabling our customers to leverage the benefits of different cloud platforms for different use cases with broader geographic reach and helping them avoid infrastructure vendor lock-in.
Partnerships
- We intend to continue to cultivate our relationships with developers through continued investment in and growth of our MongoDB Advocacy Hub, User Groups and MongoDB University.
Legal & Regulatory Risks (Item 1A, quoted)
- Our software incorporates third-party open source software, which could negatively affect our ability to sell our products and subject us to possible litigation.
- Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations.
- We have been, and may in the future be, subject to intellectual property rights claims by third parties, which may be costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies.
- Changes in laws and regulations related to the internet or changes in the internet infrastructure itself may diminish the demand for our software and could have a negative impact on our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRWV | CoreWeave, Inc. | USD 55.6 | ▼ 10.06% |
| VRSN | VeriSign, Inc. | USD 304.59 | ▼ 0.87% |
| OKTA | Okta, Inc. | USD 201.33 | ▼ 3.5% |
| CPAY | Corpay, Inc. | USD 415.01 | ▲ 1.83% |
| ZS | Zscaler, Inc. | USD 237.76 | ▲ 2.78% |
| FFIV | F5, Inc. | USD 450.08 | ▼ 1.86% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:44 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt